Sepsis
Sepsis is a potentially life-threatening condition that arises when the body's overreactive immune response to a bacterial infection causes injury to its own tissues and organs. This excessive immune response can lead to severe tissue damage and organ failure.
Health Outcomes
- Absence of Treatment-Associated Bacterial Translocation
- Accelerated Innate Immune Response Recovery
- Accelerated Recovery in Immunocompromised Individuals
- Accelerated Recovery in Immunocompromised Mice
- Adverse Safety Concern from Antimicrobial Resistance
- Alleviated Organ Injury from E. coli O78
- Altered Innate Immune Response
- Altered Neutrophil Fungicidal Function
- Altered Systemic Immune Response
- Anti-infective Effect Against Salmonella Typhimurium
- Bifidobacterium Breve Bacteremia
- Blood Bacteremia Due to Probiotic Administration
- Changed Bicarbonate Level
- Changed Hematology Parameter
- Changed Magnesium Level
- Decreased Interferon-Gamma Level
- Decreased Oxygen Saturation
- Delayed Onset of Bacteremia
- Developed Septicemia
- Diagnosis of Meningitis
- Disrupted Bacterial Cell Membranes
- Elevated Interleukin-8 Levels
- Elevated Lactate Levels
- Elevated Serum Metabolites in Response to Inflammation
- Elevated Viable Bacterial Counts
- Enhanced Activation of Peritoneal Macrophages
- Enhanced Anti-Infective Properties
- Enhanced Antimicrobial Resistance
- Enhanced Antipathogenic Activity
- Enhanced Disease Resistance
- Enhanced Hemocyte Count
- Enhanced Host Defense Peptides Activation
- Enhanced Immune Capacity
- Enhanced Immune Profile
- Enhanced Immune Resistance
- Enhanced Immune Status
- Enhanced Innate Immune Cell Activity
- Enhanced Leukocyte Recruitment
- Enhanced Negative Regulation of TLR Activity
- Enhanced Phagocytic Activity
- Enhanced Phagocytic Activity of Head Kidney Leukocytes
- Enhanced Phagocytic Activity of Peritoneal Macrophages
- Enhanced Phagocytic Capacity of Leukocytes
- Enhanced Phagocytic Capacity of Mononuclear Phagocytes
- Enhanced Phagocytic Capacity of Polymorphonuclear Phagocytes
- Enhanced Pro-Inflammatory Cytokine Response
- Enhanced Protection Against Infection
- Enhanced Protection Against Streptococcus Pyogenes Infection
- Enhanced Resistance to Bacterial Infections
- Enhanced Serum Peroxidase Activity
- Enhanced Serum-Mediated E. coli Killing
- Enhanced Systemic Immune Response
- Improved Anti-infection Response
- Improved Antibiotic Sensitivity
- Improved Antimicrobial Production
- Improved Bacterial Survival Rate
- Improved Bacterial Viability Under Stress
- Improved Bactericidal Function of Phagocytic Cells
- Improved Cardiac Muscle Contractile Performance
- Improved Granulocyte Oxidative Burst
- Improved Host Health
- Improved Host Immunity
- Improved Immune Cell Counts
- Improved Immune Cell Function
- Improved Immune Function
- Improved Immune Homeostasis
- Improved Immune Response
- Improved Immune System Activity
- Improved Immunity
- Improved Immunological Response
- Improved Innate Immune Response
- Improved Lactate Clearance
- Improved Leukocyte Recruitment
- Improved Lower Limit of Detection
- Improved Lymphocyte Count
- Improved Monocyte Phagocytic Activity
- Improved Neutrophil Function
- Improved Overall Survival During Infection
- Improved Oxygenation Index
- Improved Pathogen Clearance from Blood
- Improved Phagocyte-mediated Bactericidal Activity
- Improved Phagocytic Activity of Granulocytes
- Improved Phagocytic Capacity of Polymorphonuclear Cells
- Improved Phagocytic Function
- Improved Phagocytosis
- Improved Recovery in Immunocompromised Individuals
- Improved Serum Bactericidal Activity
- Improved Serum Protein Levels
- Improved Serum-Mediated Pathogen Killing
- Improved Surface Properties for Reduced Microbial Colonization
- Improved Survival
- Improved Survival Rate After Bacterial Challenge
- Improved Survival Rate Against Infection
- Improved Survival Rate Following Infection
- Improved Survival at 24 Months
- Improved Treatment Safety
- Incidence of Late-Onset Sepsis
- Increased Adverse Events
- Increased Aggregation of Streptococcus agalactiae
- Increased Angiopoietin Level
- Increased Anion Gap
- Increased Anti-Apoptotic Response Against Bacterial Infection
- Increased Antibacterial Activity
- Increased Antimicrobial Resistance
- Increased Bacteremia
- Increased Bacteremia Incidence
- Increased Bacterial Translocation
- Increased Blood Lactate Level
- Increased Blood Lactate Levels
- Increased Body Temperature
- Increased Bone Marrow Myelopoiesis
- Increased CD14+HLA-DR+ Cells in Peripheral Blood
- Increased Clostridium perfringens Density
- Increased Complement Component Levels
- Increased Cytokine Production
- Increased Cytokine Production in Peripheral Blood Mononuclear Cells
- Increased Cytokine Secretion
- Increased Days Alive and Out of Hospital
- Increased Detection Time in Blood Cultures
- Increased Fever
- Increased Glycine Level
- Increased Granulocyte Count
- Increased Haemolymph Melanization
- Increased Hemocyte Density
- Increased IgM Concentration
- Increased Immune Cell Presence
- Increased Infection
- Increased Lactate Level
- Increased Lactate Levels
- Increased Lactic Acid Levels
- Increased Late-Onset Sepsis Incidence
- Increased Length
- Increased Length of Hospitalization Due to Vancomycin Resistance
- Increased Leukocyte Count
- Increased Mortality
- Increased Mortality Rate with Vancomycin Resistance
- Increased Mortality in Patients with Enterococcal Bacteremia
- Increased Neonatal Death
- Increased Nitrate Level
- Increased Nitric Oxide Level
- Increased Nitrite Level
- Increased Occurrence of Serious Adverse Events
- Increased Opsonophagocytic Activity
- Increased Phagocytic Index
- Increased Plasma Nitric Oxide Levels
- Increased Portal Endotoxin Levels
- Increased Pro-inflammatory Cytokine TNFα Levels
- Increased Pro-inflammatory Cytokines in Early Healing Phase
- Increased Rate of Recurrent Bacteremia
- Increased Resting Energy Expenditure
- Increased Resting Metabolic Rate
- Increased Risk of E. faecium Infection
- Increased Serum Alternative Complement Activity
- Increased Serum Lysozyme Levels
- Increased Short-Term Serum IgM Levels
- Increased Superoxide Dismutase Levels
- Increased Survival Against Pathogens
- Increased Survival During Pathogenic Exposure
- Increased Survival Rate Against A. hydrophila
- Increased Survival Rate Against E. coli Infection
- Increased TNF-α Production
- Increased Uncoupling Protein 2 Expression
- Increased Uncoupling Protein 2 Level
- Induction of Antimicrobial Chemokines
- Inhibited ESBL-Positive Escherichia Coli Growth
- Inhibited Pathogenic Microbes
- Invasive Saccharomyces Infection
- Maintenance of NK Cell Activity
- Moderate High-Level Gentamicin Resistance
- Modulated Cytokine Levels
- Modulated Cytokine Production
- Modulated Inflammation and Coagulation Interaction
- Modulated Innate Immune Response
- Multiorgan Failure
- Necrotizing Enterocolitis Stage II
- No Change in Sepsis Risk
- No Eradication of Staphylococcus aureus at Extra-Gastrointestinal Sites
- No Measurable IFN-Alpha Induction
- No Reduced Risk of Necrotizing Enterocolitis
- No Significant Change in Blood Bacterial Detection
- Occurrence of Adverse Events
- Occurrence of Fungemia
- Occurrence of Septic Shock
- Paralysis Due to Salmonella Infection
- Presence of Multidrug-Resistant Sepsis
- Preserved Anti-pseudomonal Activity
- Prevented Bloodstream Infection
- Prevention of Bloodstream Pathogen Dissemination
- Probiotic-Related Infection
- Prolonged Bacteraemia
- Protection Against Cellular Damage Induced by Pathogens
- Protection Against Pathogen Dissemination
- Recovered from Bacteremia without Sequelae
- Reduced 3-Nitrotyrosine Level
- Reduced Acute Kidney Injury
- Reduced Acute Phase Response
- Reduced Adhesion of Streptococcus agalactiae
- Reduced Arginine Level
- Reduced BCG Phagocytic Intake
- Reduced Bacteremia
- Reduced Bacteremia Incidence
- Reduced Bacterial Detection in Blood
- Reduced Bacterial Infection Severity
- Reduced Bacterial Levels in Blood
- Reduced Bacterial Load
- Reduced Bacterial Load in Blood
- Reduced Bacterial Toxin Production
- Reduced Bacterial Translocation to Mesenteric Lymph Nodes
- Reduced Bicarbonate Level
- Reduced Blood Lactate Levels
- Reduced Body Temperature
- Reduced Brain Abscess Incidence
- Reduced Cardiac Output
- Reduced Cell Attachment due to Enterovirulent Bacteria
- Reduced Circulating Monocytes
- Reduced Clinical Sepsis
- Reduced Clostridium Species Counts
- Reduced Colonization with Multiple Organisms
- Reduced Cumulative Mortality After Infection
- Reduced Cumulative Mortality from Vibrio vulnificus
- Reduced Cytokine Secretion in Dendritic Cells
- Reduced Defense Gene Activity for Gram-Negative Pathogens
- Reduced Duration of Hospitalization
- Reduced Duration of Infectious Diseases
- Reduced Duration of Mechanical Ventilation
- Reduced Duration of Nosocomial Infections
- Reduced Electrolyte Level
- Reduced Exertional Heat Stress-Induced Endotoxemia
- Reduced Fever
- Reduced Fever Incidence
- Reduced Fibrinogen Level
- Reduced Free Triiodothyronine
- Reduced Fresh Frozen Plasma Transfusion
- Reduced Glucose Level
- Reduced Gram-Negative Bacteria Count
- Reduced Granulocyte Levels
- Reduced Group B Streptococcus Activity
- Reduced Harmful Bacterial Populations
- Reduced Hematocrit
- Reduced Hemocyte Apoptosis
- Reduced Hospital Mortality Rate
- Reduced Hospital Readmission Risk
- Reduced Hospitalization Duration
- Reduced Immune Cell Activity
- Reduced Immune Protection
- Reduced Impact of Gram-negative Microorganisms
- Reduced In-hospital Mortality
- Reduced Incidence of Bacterial Infections
- Reduced Incidence of Common Infectious Diseases
- Reduced Incidence of Hyperbilirubinemia
- Reduced Incidence of Infections
- Reduced Incidence of Invasive Infections
- Reduced Induced Innate Immune Response
- Reduced Infant Infections
- Reduced Infection Rate
- Reduced Infection Severity
- Reduced Infectious Complication
- Reduced Inotropic Support Requirement
- Reduced Intensive Care Unit Mortality
- Reduced Intensive Care Unit Stay
- Reduced Isoleucine Level
- Reduced LPS Secretion
- Reduced LPS Translocation
- Reduced Lactate Concentration
- Reduced Late-Onset Sepsis
- Reduced Left Ventricular End-Diastolic Volume
- Reduced Length of Hospitalization
- Reduced Length of Intensive Care Unit Stay
- Reduced Leukocyte Count
- Reduced Lipopolysaccharide-Binding Protein
- Reduced Listeria Monocytogenes Population
- Reduced Lysophosphatidylcholine 18:1 Level
- Reduced M1 Macrophage Population
- Reduced Mean Arterial Blood Pressure
- Reduced Mean Arterial Pressure
- Reduced Mechanical Ventilation Duration
- Reduced Mortality
- Reduced Mortality Post-Challenge with S. agalactiae
- Reduced Mortality Post-Infection
- Reduced Mortality Rate
- Reduced Mortality Rate from Salmonella Enteritidis Infection
- Reduced Mortality from Endotoxin Shock
- Reduced Mortality from Streptococcal Infection
- Reduced NEC Severity
- Reduced NO Secretion Induced by LPS
- Reduced Need for Continuous Renal Replacement Therapy
- Reduced Neutrophil Extracellular Trap Formation
- Reduced Nitric Oxide Level
- Reduced Nontransferable Antibiotic Resistance
- Reduced Organ Failure Severity
- Reduced Organ Injury from Escherichia coli
- Reduced Oxidized Glutathione Level
- Reduced Pathogen Activity
- Reduced Pathogen Counts in Organs
- Reduced Pathogen Infection
- Reduced Pathogen Resistance
- Reduced Pathogenic Bacterial Load In Vivo
- Reduced Peripheral Blood Pressure
- Reduced Phagocytic Activity
- Reduced Platelet Counts
- Reduced Postoperative Infectious Complications
- Reduced Pulsatility Index
- Reduced Pulse Pressure
- Reduced Renal Replacement Therapy
- Reduced Respiratory Exchange Ratio
- Reduced Respiratory Rate
- Reduced Risk of Infection
- Reduced S. aureus Cell Count In Vivo
- Reduced SOFA Score
- Reduced Salmonella Enterica Invasion
- Reduced Sepsis
- Reduced Sepsis Mortality
- Reduced Serpin Level
- Reduced Serum Chemokine Levels
- Reduced Serum Haptoglobin Concentration
- Reduced Serum Haptoglobin Levels
- Reduced Short-term Mortality
- Reduced Soluble VCAM-1 Levels
- Reduced Staphylococcus aureus Viability
- Reduced Stx Production
- Reduced Survival of Listeria innocua
- Reduced Thrombocytopenia
- Reduced Time to Crisis Resolution
- Reduced Total Thyroxine Level
- Reduced Total White Blood Cell Counts
- Reduced Triiodothyronine Level
- Reduced Troponin I Level
- Reduced Use of Vasoactive Drugs
- Reduced Vasopressor Duration
- Regulated Inflammation
- Regulated Interleukin 8 Levels
- Restored Immunological Function in Immunosuppressed Mice
- Sepsis Management Improvement
- Septicemia Incidence
- Significant Bacterial Translocation with Intraperitoneal Administration
- Stabilized Cytokine Levels
- Suppressed Pathogenic Growth
- Sustained Immune Function
- White Blood Cell Count
- Worsened Acidosis